Literature DB >> 24362329

Daptomycin exerts rapid bactericidal activity against Bacillus anthracis without disrupting membrane integrity.

Yu-hua Xing1, Wei Wang1, Su-qin Dai2, Ti-yan Liu2, Jun-jie Tan2, Guo-long Qu2, Yu-xia Li2, Yan Ling2, Gang Liu2, Xue-qi Fu3, Hui-peng Chen2.   

Abstract

AIM: To examine whether the novel cyclic lipopeptide antibiotic daptomycin could be used to treat anthrax and to study the mechanisms underlying its bactericidal action against Bacillus anthracis.
METHODS: Spore-forming B anthracis AP422 was tested. MIC values of antibiotics were determined. Cell membrane potential was measured using flow cytometric assays with membrane potential-sensitive fluorescent dyes. Cell membrane integrity was detected using To-Pro-3 iodide staining and transmission electron microscopy. K(+) efflux and Na(+) influx were measured using the fluorescent probes PBFI and SBFI-AM, respectively.
RESULTS: Daptomycin exhibited rapid bactericidal activity against vegetative B anthracis with a MIC value of 0.78 μg/mL, which was comparable to those of ciprofloxacin and penicillin G. Furthermore, daptomycin prevented the germinated spores from growing into vegetative bacteria. Daptomycin concentration-dependently dissipated the membrane potential of B anthracis and caused K(+) efflux and Na(+) influx without disrupting membrane integrity. In contrast, both ciprofloxacin and penicillin G did not change the membrane potential of vegetative bacteria or spores. Penicillin G disrupted membrane integrity of B anthracis, whereas ciprofloxacin had no such effect.
CONCLUSION: Daptomycin exerts rapid bactericidal action against B anthracis via reducing membrane potential without disrupting membrane integrity. This antibiotic can be used as an alternate therapy for B anthracis infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24362329      PMCID: PMC4651213          DOI: 10.1038/aps.2013.159

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  27 in total

1.  In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne.

Authors:  C H Choe; S S Bouhaouala; I Brook; T B Elliot; G B Knudson
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.

Authors:  M Wu; R E Hancock
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

3.  Daptomycin: a novel agent for Gram-positive infections.

Authors:  F P Tally; M Zeckel; M M Wasilewski; C Carini; C L Berman; G L Drusano; F B Oleson
Journal:  Expert Opin Investig Drugs       Date:  1999-08       Impact factor: 6.206

4.  Uptake of sodium in protoplasts of salt-sensitive and salt-tolerant cultivars of rice, Oryza sativa L. determined by the fluorescent dye SBFI.

Authors:  Md Abdul Kader; Sylvia Lindberg
Journal:  J Exp Bot       Date:  2005-11-07       Impact factor: 6.992

5.  In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones.

Authors:  I Brook; T B Elliott; H I Pryor; T E Sautter; B T Gnade; J H Thakar; G B Knudson
Journal:  Int J Antimicrob Agents       Date:  2001-12       Impact factor: 5.283

6.  Antimicrobial susceptibilities of diverse Bacillus anthracis isolates.

Authors:  Pamala R Coker; Kimothy L Smith; Martin E Hugh-Jones
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

7.  Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique.

Authors:  D Novo; N G Perlmutter; R H Hunt; H M Shapiro
Journal:  Cytometry       Date:  1999-01-01

8.  Selection of Bacillus anthracis isolates resistant to antibiotics.

Authors:  A Athamna; M Athamna; N Abu-Rashed; B Medlej; D J Bast; E Rubinstein
Journal:  J Antimicrob Chemother       Date:  2004-06-17       Impact factor: 5.790

9.  In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis.

Authors:  Valerie Laganas; Jeffrey Alder; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

10.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Authors:  J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  10 in total

Review 1.  Therapeutic cyclic lipopeptides mining from microbes: latest strides and hurdles.

Authors:  Seema Patel; Shadab Ahmed; J Satya Eswari
Journal:  World J Microbiol Biotechnol       Date:  2015-06-04       Impact factor: 3.312

2.  Membrane activity profiling of small molecule B. subtilis growth inhibitors utilizing novel duel-dye fluorescence assay.

Authors:  S McAuley; A Huynh; T L Czarny; E D Brown; J R Nodwell
Journal:  Medchemcomm       Date:  2018-02-15       Impact factor: 3.597

3.  A Chemical Inhibitor of Cell Growth Reduces Cell Size in Bacillus subtilis.

Authors:  Scott McAuley; Stephen Vadia; Charul Jani; Alan Huynh; Zhizhou Yang; Petra Anne Levin; Justin R Nodwell
Journal:  ACS Chem Biol       Date:  2019-03-18       Impact factor: 5.100

4.  Optical Screening for Rapid Antimicrobial Susceptibility Testing and for Observation of Phenotypic Diversity among Strains of the Genetically Clonal Species Bacillus anthracis.

Authors:  Heather P McLaughlin; Amy S Gargis; Pierre Michel; David Sue; Linda M Weigel
Journal:  J Clin Microbiol       Date:  2017-01-04       Impact factor: 5.948

Review 5.  Alternative pre-approved and novel therapies for the treatment of anthrax.

Authors:  Breanne M Head; Ethan Rubinstein; Adrienne F A Meyers
Journal:  BMC Infect Dis       Date:  2016-11-03       Impact factor: 3.090

Review 6.  Current Status and Trends in Prophylaxis and Management of Anthrax Disease.

Authors:  Vladimir Savransky; Boris Ionin; Joshua Reece
Journal:  Pathogens       Date:  2020-05-12

Review 7.  Zoonoses under our noses.

Authors:  Alice R Cross; Victoria M Baldwin; Sumita Roy; Angela E Essex-Lopresti; Joann L Prior; Nicholas J Harmer
Journal:  Microbes Infect       Date:  2018-06-18       Impact factor: 2.700

8.  Antibacterial efficacy and possible mechanism of action of 2-hydroxyisocaproic acid (HICA).

Authors:  Amila S N W Pahalagedara; Steve Flint; Jon Palmer; Gale Brightwell; Tanushree B Gupta
Journal:  PLoS One       Date:  2022-04-01       Impact factor: 3.240

9.  Glucose-Induced Cyclic Lipopeptides Resistance in Bacteria via ATP Maintenance through Enhanced Glycolysis.

Authors:  Wen-Bang Yu; Qian Pan; Bang-Ce Ye
Journal:  iScience       Date:  2019-10-07

Review 10.  More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin.

Authors:  Declan Alan Gray; Michaela Wenzel
Journal:  Antibiotics (Basel)       Date:  2020-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.